PRAXIS PRECISION MEDICINES I's ticker is PRAX and the CUSIP is 74006W108. A total of 100 filers reported holding PRAXIS PRECISION MEDICINES I in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,013,800 | +64.6% | 8,780,000 | +10.7% | 0.03% | +70.0% |
| Q2 2023 | $9,120,234 | +486.5% | 7,930,638 | +312.6% | 0.02% | +566.7% |
| Q1 2023 | $1,555,110 | -71.0% | 1,922,262 | -14.8% | 0.00% | -76.9% |
| Q4 2022 | $5,369,378 | +4.9% | 2,256,041 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $5,121,000 | +19.0% | 2,256,041 | +28.5% | 0.01% | +30.0% |
| Q2 2022 | $4,302,000 | -46.8% | 1,756,041 | +121.7% | 0.01% | -33.3% |
| Q1 2022 | $8,087,000 | -40.7% | 792,081 | +14.4% | 0.02% | -40.0% |
| Q4 2021 | $13,634,000 | +20.5% | 692,081 | +13.1% | 0.02% | +13.6% |
| Q3 2021 | $11,317,000 | +5.5% | 612,081 | +4.3% | 0.02% | +4.8% |
| Q2 2021 | $10,732,000 | -20.5% | 587,081 | +42.5% | 0.02% | -25.0% |
| Q1 2021 | $13,500,000 | -40.5% | 412,081 | 0.0% | 0.03% | -42.9% |
| Q4 2020 | $22,673,000 | – | 412,081 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,469,665 | $3,497,803 | 4.70% |
| Ally Bridge Group (NY) LLC | 630,584 | $1,500,790 | 1.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,855,989 | $6,797,254 | 1.35% |
| 72 Investment Holdings, LLC | 988,995 | $2,353,808 | 1.08% |
| MPM BioImpact LLC | 610,000 | $1,451,800 | 0.38% |
| Octagon Capital Advisors LP | 800,000 | $1,904,000 | 0.30% |
| PFM Health Sciences, LP | 2,777,467 | $6,610,371 | 0.24% |
| HARVARD MANAGEMENT CO INC | 778,517 | $1,852,870 | 0.23% |
| Eventide Asset Management | 3,518,062 | $8,372,988 | 0.16% |
| Artal Group S.A. | 1,200,000 | $2,856 | 0.16% |